Clinical Trial Update: Sleep and Cognition After Atripla to Stribild Switch [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing sleep and cognition after switching HIV treatment from Atripla to Stribild; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)
• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)

Snippet

Sponsor: University of Hawaii | Conditions: HIV | Phase 4 | Status: UNKNOWN